Company Filing History:
Years Active: 2009
Title: Rong L He: Innovator in Immunology and Inflammatory Response Modulation
Introduction: Rong L He is a prominent inventor based in Chicago, IL (US), known for his significant contributions to the field of immunology. His research focuses on the modulation of inflammatory and immune responses, which has important implications for various medical conditions.
Latest Patents: Rong L He holds a patent titled "Toll-like receptor agonists and antagonists and methods of use thereof." This patent relates to compositions and methods for modulating inflammatory and immune responses through the binding of Serum Amyloid A (SAA) to Toll-like receptor 2 (TLR2) in subjects, including humans and other animals. The studies associated with this patent demonstrate that SAA is a potent inducer of macrophage secretion of Granulocyte-Colony Stimulating Factor (G-CSF), leading to neutrophilia in mice. The research establishes a link between increased SAA concentration and TLR2-mediated inflammatory responses.
Career Highlights: Rong L He is affiliated with the University of Illinois, where he conducts his research and develops innovative solutions to complex immunological challenges. His work has garnered attention for its potential to influence therapeutic strategies in treating inflammatory diseases.
Collaborations: He has collaborated with notable colleagues, including Richard D Ye and Ni Cheng, to advance research in the field of immunology. Their combined expertise contributes to the development of novel approaches to understanding and manipulating immune responses.
Conclusion: Rong L He is a key figure in the field of immunology, with a focus on innovative methods to modulate inflammatory responses. His patent and research efforts highlight the importance of understanding the mechanisms behind immune system regulation.